Executive Summary
The August 18, 2026 filings reveal a market with clear winners and losers, driven by strategic pivots and execution quality. A key theme is the **'growth vs. profitability trade-off'**, where several companies (Akzo Nobel, Hexagon Nutrition, Flair Writing) are sacrificing margins for market share, while others (Kusumgar, Natco Pharma) show stellar margin expansion.
The **capital markets remain active** with a significant open offer (Lippi Systems), multiple preferential allotments (JMJ Fintech, Natural Capsules, Alka India), and a major debt raise by Bajaj Finance. **Insider activity is mixed**: a promoter buy in Signet Industries contrasts with director exits at Radaan Mediaworks. **Forward-looking guidance is a critical differentiator**: Flair Writing and Moneyboxx provided clear targets, while Kusumgar declined, citing structural uncertainty. The **energy transition theme gains traction** with a large solar EPC contract for Advait Energy. Overall, the digest points to selective opportunities in companies with strong execution, clear guidance, and improving fundamentals, while caution is warranted for those with margin compression, governance churn, or opaque outlooks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance · IPO · Debt securities · Open offer · Corporate action · Insider trading
Tracking the trend? Catch up on the prior India Stock Market Daily Regulatory Digest digest from August 17, 2026.
Investment Signals (10)
- Kusumgar Ltd ↓ (BULLISH)▲
Revenue surged 102% YoY to INR247.2 Cr, EBITDA margin expanded 900 bps to 31%, and PAT jumped to INR42.6 Cr (17% margin) from INR6.6 Cr (5% margin) a year ago. The company is newly listed (July 15, 2026) and is executing on ready parachute contracts.
- Natco Pharma ↓ (BULLISH)▲
Normalized PAT grew 34% QoQ to INR206.5 Cr, driven by a strong flu season boosting associate Adcock Ingram's profit share to INR84.3 Cr (vs. typical INR35-40 Cr). The company also raised its stake in Adcock to 49% and plans a INR2,000 Cr fundraise for M&A.
- Flair Writing Industries ↓ (BULLISH)▲
Reiterated FY27 revenue growth guidance of 15% and expects EBITDA margins to improve to 17-18% from 16.7% in Q1. Creative Products (+23% YoY) and Steel Bottles (+54% YoY) are high-growth segments expected to reach 35-38% of revenue in FY27.
- Moneyboxx Finance ↓ (BULLISH)▲
Deliberate strategic shift from unsecured to secured lending is showing results. Secured AUM mix improved to ~75% (from 49% in June 2025), and the company expects operating leverage and profitability to improve as the stronger portfolio scales.
- Advait Energy Transitions ↓ (BULLISH)▲
Material subsidiary won a turnkey EPC contract for a 200 MW solar project valued at INR116 Cr, to be executed within 12 months. This adds to a strong order book in the renewable energy space.
- Akzo Nobel India (JSW Dulux) (BULLISH)▲
Revenue grew 18.8% YoY with 25% volume growth, and industrial business grew over 25%. PAT of INR135.5 Cr included one-off items, but the underlying business momentum is strong.
- RVNL (BULLISH)▲
PAT grew 21.72% YoY to INR155 Cr, and the order book stands at a robust INR93,492 Cr. The company targets INR20,000-25,000 Cr in new orders for FY27, with INR5,500 Cr already secured in Q1.
- Hexagon Nutrition ↓ (BULLISH)▲
Revenue grew 43.2% YoY to INR104.3 Cr, driven by strong demand. The company is newly listed (June 2026) and is investing for growth, though margins contracted.
- Signet Industries ↓ (BULLISH)▲
Promoter Mukesh Sangla acquired 13,904 shares (0.05% of capital) via open market purchase on August 17, 2026, increasing his stake to 4.02%. This is a small but positive insider signal.
- JMJ Fintech ↓ (BULLISH)▲
Board approved a preferential issue at a 101% premium to the floor price, signaling strong confidence from the allottees. A final dividend of INR0.15/share was also recommended.
Risk Flags (9)
- Natco Pharma↓ [HIGH RISK]▼
Consolidated total revenues declined 42.9% YoY to INR794.4 Cr, primarily due to negligible Lenalidomide revenue. The Crop Health Sciences segment remains loss-making, though breakeven is expected for FY27.
- Akzo Nobel India (JSW Dulux) [MEDIUM RISK]▼
Gross margin fell to 37.4% due to low inventory (60 days vs industry 110-120 days) and reclassification of promotional spends. EBITDA margin declined to 11.9% as the company reinvested in R&D and added ~160 people.
- Hexagon Nutrition↓ [MEDIUM RISK]▼
EBITDA margin contracted to 11.3% from 13.8% in Q1 FY26, reflecting product mix changes and growth investments. The company is newly listed and needs to demonstrate margin recovery.
- Flair Writing Industries↓ [MEDIUM RISK]▼
PAT grew only 0.5% YoY to INR29.1 Cr due to lower other income and elevated raw material costs from geopolitical tensions. Exports remained flat YoY at INR43 Cr.
- Kusumgar Ltd↓ [HIGH RISK]▼
Revenue declined 21% sequentially from INR312.8 Cr in Q4 FY26, attributed to a pull-forward of export volumes. Management declined to provide forward guidance due to structural uncertainties in government tenders and product approvals.
- Radaan Mediaworks India↓ [MEDIUM RISK]▼
Two directors resigned effective August 18, 2026, including an Independent Director and a Non-Executive Director, both citing personal commitments. This reduces board independence and non-executive representation.
- Sudarshan Pharma Industries↓ [HIGH RISK]▼
The Ratna Lifescience subsidiary reported a PAT of only INR0.51 Cr in FY26, a significant decline from INR7.8 Cr in FY25, indicating a sharp drop in profitability.
- Hindustan Copper↓ [MEDIUM RISK]▼
Revenue from operations declined to INR1,717 Cr in FY24-25 from INR2,071 Cr in FY23-24, and profit before tax fell to INR395.66 Cr from INR471.77 Cr, indicating a near-term downturn despite long-term expansion plans.
- Lippi Systems↓ [MEDIUM RISK]▼
The open offer by Vinesh Shivji Dholu and others saw minimal public acceptance—only 1,000 shares were tendered out of a potential 33.82 lakh, resulting in the acquirers holding only 74.58% post-offer. This suggests a lack of confidence from public shareholders in the offer price of INR56.84.
Opportunities (9)
- Natco Pharma↓ (OPPORTUNITY)◆
The company plans a INR2,000 Cr fundraise for potential M&A, and its increased stake in Adcock Ingram (49%) provides a strong earnings buffer. The normalized PAT growth of 34% QoQ and strong flu season in South Africa are positive catalysts.
- Flair Writing Industries↓ (OPPORTUNITY)◆
The company's guidance for 15% revenue growth and margin improvement to 17-18% provides a clear catalyst. The high-growth Creative Products and Steel Bottles segments are expected to reach 35-38% of revenue in FY27, driving mix improvement.
- Kusumgar Ltd↓ (OPPORTUNITY)◆
Despite the sequential decline, the company's 102% YoY revenue growth and 900 bps margin expansion are exceptional. The stock is newly listed and may offer a compelling entry point if the company can stabilize its order flow.
- Moneyboxx Finance↓ (OPPORTUNITY)◆
The strategic pivot to secured lending is a positive long-term move. With secured AUM at 75% and stable collection efficiency of 92.3%, the company is well-positioned for improved profitability as the portfolio scales.
- Advait Energy Transitions↓ (OPPORTUNITY)◆
The INR116 Cr solar EPC contract adds to a growing order book. The company is a beneficiary of India's renewable energy push and could see further order wins.
- RVNL (OPPORTUNITY)◆
With an order book of INR93,492 Cr and a target of INR20,000-25,000 Cr in new orders for FY27, the company has strong revenue visibility. The Vande Bharat sleeper train project (INR14,400 Cr) is a key catalyst, with the first prototype expected in December 2026.
- Blue Jet Healthcare↓ (OPPORTUNITY)◆
The company raised INR8,000 Cr via QIP, acquired land for a new facility, and is investing in GLP-1 intermediates and peptide chemistry. With a PAT margin of 26% and strong credit ratings, it is well-capitalized for growth.
- Akzo Nobel India (JSW Dulux) (OPPORTUNITY)◆
The 25% volume growth and strong industrial business performance are positive. The company's underlying gross margin is estimated at 39.5-40%, suggesting margin recovery potential as inventory normalizes.
- Natural Capsules↓ (OPPORTUNITY)◆
The EGM on September 9, 2026, will seek approval for preferential allotment of shares and warrants to the promoter at INR160 each. This could signal promoter confidence and provide a floor for the stock price.
Sector Themes (6)
- Growth vs. Profitability Trade-off◆
Multiple companies (Akzo Nobel, Hexagon Nutrition, Flair Writing) are reporting strong revenue growth but compressed margins. This suggests a competitive environment where companies are investing in market share, R&D, and capacity, which could pay off in the long term but pressures near-term profitability.
- Capital Raising and Corporate Actions◆
The market is seeing a flurry of capital-raising activities, including a large NCD issue by Bajaj Finance (INR498 Cr), preferential allotments by JMJ Fintech, Natural Capsules, and Alka India, and a rights issue by Jaykay Enterprises. This indicates a healthy appetite for capital among corporates and investors.
- Energy Transition Momentum◆
The solar EPC contract win by Advait Energy Transitions (INR116 Cr) and Hindustan Copper's plan to invest INR7,000 Cr to expand mining capacity highlight the ongoing momentum in the energy transition and related infrastructure sectors.
- Selective Insider Confidence◆
Insider activity is mixed but notable. A promoter buy in Signet Industries is a positive signal, while director exits at Radaan Mediaworks are a concern. The minimal public acceptance in the Lippi Systems open offer suggests a lack of confidence in the offer price.
- Guidance as a Key Differentiator◆
Companies providing clear forward guidance (Flair Writing, Moneyboxx, RVNL) are offering investors a roadmap for growth. In contrast, Kusumgar's decision to decline guidance due to structural uncertainty creates a risk premium for the stock.
- Newly Listed Companies in Focus◆
Several recently listed companies (Kusumgar, Hexagon Nutrition) are reporting their first quarterly results, offering investors a fresh look at their performance. These stocks may experience higher volatility as the market digests the new data.
Watch List (8)
-
Watch for margin improvement towards the 17-18% guidance for FY27. The next quarterly results will be crucial to see if cost pressures ease and the high-growth segments continue to outperform. [Next earnings: likely November 2026]
-
Monitor the progress of the INR2,000 Cr fundraise and any M&A announcements. Also watch for the trajectory of Lenalidomide revenue and the performance of the Crop Health Sciences segment. [Fundraise timeline: TBD]
-
The company's ability to secure new government tenders and product approvals will be critical. Watch for any forward guidance or order book updates that could reduce the current uncertainty. [Next earnings: likely November 2026]
-
Monitor for further order wins in the renewable energy space. The execution of the 200 MW solar project over the next 12 months will be a key test of its subsidiary's capabilities. [Project completion: August 2027]
-
The Rights Issue Committee meeting on August 20, 2026, will decide the Issue Price and Entitlement Ratio. This is a key catalyst for the stock. [Meeting: August 20, 2026]
-
The EGM on September 9, 2026, will vote on the preferential allotment to the promoter. The outcome and the subsequent conversion of warrants will be important to watch. [EGM: September 9, 2026]
-
The company's ability to scale its secured loan book and achieve operating leverage will be key. Watch for AUM growth and collection efficiency trends in the coming quarters. [Next earnings: likely November 2026]
- RVNL👁
Monitor the progress of the Vande Bharat sleeper train project (first prototype expected December 2026) and the resolution of payment issues with BSNL for the BharatNet project. [Prototype: December 2026]
Filing Analyses
(50)
18-08-2026
Sasken Technologies Limited has informed the stock exchanges about scheduled analyst and institutional investor meetings with MKP Securities and Nippon AIF on August 20, 2026, both to be held virtually. The company stated that any information shared during these meetings will be based on publicly available investor presentations and documents.
- · Meetings scheduled for August 20, 2026: MKP Securities (9:30-10:30 AM IST) and Nippon AIF (2:30-3:30 PM IST), both virtual.
- · The investor presentation for Q1 FY27 and previous quarters is already publicly available on the company's website.
18-08-2026
Thomas Scott (India) Limited has informed the stock exchanges that the audio recording of its Q1 FY 2026-27 earnings call, held on August 17, 2026, is now available on the company's website. This is a routine procedural disclosure under SEBI Listing Regulations, providing no specific financial or operational details.
- · The earnings call was held on Monday, August 17, 2026, at 12:00 PM IST.
- · The audio recording is hosted at thomasscott.org/financial-results/audio/Concall Audio Recording Q1 FY 2026-27.mp3.
18-08-2026
Chemkart India Limited's Board of Directors, at a meeting on August 18, 2026, approved the appointment of M/s Prem Chand Jain & Co. as Statutory Auditors and M/s Nirmal Tiwari & Associates as Secretarial Auditors, each for a five-year term from FY 2026-27 to FY 2030-31, subject to shareholder approval at the upcoming 7th Annual General Meeting (AGM). The Board also approved convening the 7th AGM on September 19, 2026, via video conferencing. The filing contains no financial performance data, so no period-over-period comparisons or mixed performance metrics are available.
- · The Board meeting started at 11:30 AM IST and concluded at 12:00 PM IST on August 18, 2026.
- · M/s Prem Chand Jain & Co. has its head office in Mumbai and branch offices in Indore, Pune, Bhopal, and Ahmedabad.
- · M/s Prem Chand Jain & Co. has been recognized as a 'Strategic Partner of the Bank' by Bank of India.
- · M/s Nirmal Tiwari & Associates is registered with ICSI and has professional experience in Company Law Compliances, SEBI Listing Compliances, Secretarial Audit, and Attestation services.
- · CS Nirmal Tiwari has been appointed as the Scrutinizer for the voting process at the 7th AGM.
- · The 7th AGM will be held on Saturday, September 19, 2026, at 12:00 PM IST through video conferencing.
18-08-2026
Hindustan Copper Ltd (HCL) released an updated corporate presentation for August 2026, highlighting its position as India's sole vertically integrated copper producer with a market capitalisation of ₹51619 Crore. The company plans to invest over ₹7,000 crore in the next 5–6 years and expand mining capacity from ~4 MTPA to 12.20 MTPA by FY'30. However, physical production in FY25-26 (Q1) and financial performance for the same period are not fully detailed; revenue from operations declined in FY24-25 to ₹1,717.00 Cr from ₹2,070.97 Cr in FY23-24, and profit before tax fell to ₹395.66 Cr from ₹471.77 Cr in the prior year, indicating a near-term downturn.
- · HCL owns all operating mining leases of copper ore in India and has access to ~45% of India's copper ore reserves and resources.
- · India's total copper ore reserves/resources stand at 1660 million tonnes; copper ore reserves are 164 million tonnes.
- · Rajasthan leads with 52.25% of India's copper ore, followed by Madhya Pradesh (23.28%) and Jharkhand (15.14%).
- · HCL's copper ore reserves are 156.97 million tonnes at an average grade of 1.31%.
- · HCL's total resources (UNFC) as on 01.04.2025: 767.37 million tonnes at an average grade of 0.94%.
- · Resource increase of 198.61 million tonnes since 2018 (568.75 MT to 767.36 MT).
- · Planned exploration includes depth exploration in Sidheswar Block, Kendadih Southern Block, Rakha N-W Block, Khetri and Kolihan Lease.
- · HCL is the preferred bidder for Baghwari-Khirkhori Copper Corporate Bodal Block.
- · Per capita copper consumption in India is 0.6 kg/person vs world average 3.2 kg/person.
- · India's mine production in FY 24-25 is 27.42 Kt, ~0.12% of world production.
- · Dividend remained flat at ₹88.97 Cr for FY 24-25 and FY 25-26.
- · Capital expenditure target for FY 25-26: ₹481 Crore (MoU target) vs ₹428 Crore actual.
- · Employee strength as on 31st July 2026: 1134.
- · Credit rating: Short Term ICRA A1+, Long Term ICRA AA+ (Stable) as of October 2025.
- · Joint venture: KABIL (HCL 30%), CCL (HCL 74%).
- · MoU with CODELCO, Chile for capacity building and knowledge sharing.
18-08-2026
Yaashvi Jewellers Limited has listed its equity shares on the BSE SME Platform, effective August 18, 2026. Consequently, the company's CIN changed from U27200RJ2016PLC056519 to L27200RJ2016PLC056519, reflecting its conversion from a private to a public limited company. The company is now listed on a stock exchange with an authorized capital of ₹18,00,00,000 and a paid-up capital of ₹17,62,15,240.
- · Company incorporated on December 13, 2016, under ROC Jaipur.
- · Company status is ACTIVE compliant.
- · Last AGM held on September 30, 2025; last balance sheet dated March 31, 2025.
- · Company is classified as a public, non-government, company limited by shares.
18-08-2026
Bajaj Finance Limited has allotted 50,000 secured redeemable non-convertible debentures (NCDs) on a private placement basis, aggregating to Rs. 498.22 crore. The NCDs have a face value of Rs. 1 Lakh each, carry a coupon rate of 7.79% p.a., and will mature on 4 July 2036. The debentures are proposed to be listed on the Wholesale Debt Market Segment of BSE Limited.
- · ISIN: INE296A07UC7 (Re-issue)
- · Tenure: 3608 residual days (allotted 18 August 2026, maturity 4 July 2036)
- · Coupon payment frequency: Annually, first payment on 6 July 2027
- · Security: First pari-passu charge on book debts/loan receivables with security cover not less than 1.00 times the aggregate outstanding value
- · Debentures are redeemable on maturity
- · Meeting of Debenture Allotment Committee commenced at 12:05 p.m. and concluded at 12:25 p.m.
18-08-2026
Sudarshan Pharma Industries Limited has released an investor presentation for August 2026, highlighting its diversified specialty chemicals and pharmaceutical business, global reach, and key milestones. The company achieved a total export turnover of Rs.21.85 Cr in FY 25-26 and targets Rs.100 Cr for FY 26-27. However, the presentation shows that the company's Ratna Lifescience subsidiary, while turned around to profitability, reported a PAT of only Rs.0.51 Cr in FY26, a significant decline from Rs.7.8 Cr in FY25, indicating a sharp drop in profitability.
- · The company has a subsidiary in Poland (opened in 2024-2025).
- · SPIL has introduced a novel drug delivery system under the Love Bird brand featuring a mouth-dissolving strip with 5 products.
- · The product 'SET DOWN' combines allopathy and ayurveda for constipation relief, introduced for the first time in India.
- · The company has secured GMP certification for API intermediates and API manufacturing at its Hyderabad facility, along with ISO 9001:2015 certification.
- · The Hyderabad unit has developed about 50 potential API key starting materials and holds patent rights for some.
- · The company has a 70% ownership in Sudarshan Maven Lifescience Private Limited.
18-08-2026
Moneyboxx Finance reported Q1 FY27 results reflecting a deliberate strategic shift from unsecured to secured lending, with AUM at ₹832 crore (underlying +5% YoY excluding ARC impact). Disbursements moderated to ₹77 crore (from ₹92 crore in Q1 FY26) as the company stopped unsecured lending and focused on higher-ticket secured loans. While total income was ₹52.12 crore and PAT was ₹0.21 crore (vs ₹0.24 crore a year ago), the secured AUM mix improved to ~75% (from 49% in June 2025) and collection efficiency remained stable at 92.3%. The company expects operating leverage and profitability to improve as the stronger portfolio scales.
- · Moneyboxx stopped disbursement of unsecured loans from April 2026, except through partnership model and in Punjab.
- · Secured loans accounted for 87% of disbursements in Q1 FY27 vs 67% in FY26.
- · 70% of disbursements were in ticket sizes above ₹5 lakhs; 75% were to customers with bureau score ≥650.
- · Renewable energy loan disbursements crossed ₹10 crore cumulative till July 2026; in July, 15% of disbursements were renewable energy loans.
- · Company added two new NBFC lending partners in Q1: Sammaan Capital and Northern Arc.
- · Capital adequacy ratio stood at 28.65% as of June 2026.
- · Company expects institutional equity infusion in H2 FY27.
- · Moneyboxx received three gold awards and one silver award at BW Disrupt Festival of Fintech.
- · Legal actions: over 1,000 bailable warrants reached.
18-08-2026
Pasupati Acrylon Limited has dispatched a letter to shareholders providing a web link to access the Notice of the 43rd Annual General Meeting and the Annual Report for FY 2025-26. The AGM is scheduled for September 9, 2026, at the company's registered office in Moradabad, Uttar Pradesh. The filing is a routine procedural disclosure under SEBI regulations and contains no financial results or performance data.
- · AGM date: Wednesday, 9th September 2026 at 10:30 A.M.
- · Cut-off date for remote e-voting: Wednesday, 2nd September 2026
- · Remote e-voting period: Sunday, 6th September 2026 (10:00 A.M.) to Tuesday, 8th September 2026 (5:00 P.M.)
- · Annual Report and AGM Notice available at: https://pasupatiacrylon.com/wp-content/uploads/2026/08/Annual-Report-2025-26.pdf
- · Shareholders without registered email received physical letter with web link; those with registered email received electronic copies.
18-08-2026
Patanjali Foods Limited has informed shareholders about tax deduction at source (TDS) on the 3rd Interim Dividend of ₹1.50 per share (75%) for FY 2025-26 and the 1st Interim Dividend of ₹0.80 per share (40%) for FY 2026-27, with a record date of August 21, 2026. The company had already paid two interim dividends of ₹1.75 each (totaling ₹3.50 per share) for FY 2025-26. The filing details the applicable TDS rates and documentation requirements for resident and non-resident shareholders, but does not provide any financial performance metrics or period-over-period comparisons.
- · Record date for dividend entitlement is August 21, 2026.
- · Resident individuals are exempt from TDS if aggregate dividend from the company does not exceed ₹10,000 during FY 2026-27.
- · Non-resident shareholders can claim beneficial DTAA rates by submitting a Tax Residency Certificate, Form 41, and a self-declaration.
- · Shareholders must submit required documents to the RTA (Sarthak Global Limited) by August 21, 2026.
- · In the absence of a valid PAN, TDS will be deducted at 20% for resident shareholders.
- · The company has already paid a total of ₹3.50 per share as interim dividends for FY 2025-26.
18-08-2026
Natco Pharma reported Q1 FY27 consolidated total revenues of INR794.4 crore, down 42.9% YoY from INR1,390.6 crore, primarily due to lower Lenalidomide revenue. However, EBITDA margin improved to 30.9% and normalized PAT grew 34% QoQ to INR206.5 crore, driven by a strong flu season in South Africa boosting associate Adcock Ingram's profit share to INR84.3 crore (vs. typical INR35-40 crore). The company also acquired an additional 13.25% stake in Adcock Ingram in July 2026, raising total holding to 49%, and plans a INR2,000 crore fundraise for potential M&A. Domestic formulation revenue grew to INR136 crore, and Brazil revenue surged 180% to INR178 crore, but the Crop Health Sciences segment remained loss-making in Q1, though breakeven is expected for the full year.
- · Lenalidomide revenue was negligible in Q1 FY27, down from prior quarters.
- · Canada sales for Q1 FY27 were INR56 crore.
- · Crop Health Sciences segment reported a loss in Q1 FY27, but expects breakeven for FY27.
- · The company has short-term loans to pay off and capital expenditure plans.
- · R&D spend is lumpy; Q1 FY27 had lower R&D and legal costs, not a sustainable run rate.
- · The company expects FY27 gross sales of INR3,300-3,400 crore.
- · Domestic base business (excluding semaglutide) is typically ~INR107 crore per quarter; Q1 FY27 reached ~INR130 crore.
- · Adcock Ingram's strong Q1 was driven by a flu season in South Africa.
18-08-2026
Datamatics Global Services Limited has communicated to shareholders regarding tax deduction at source (TDS) on the recommended final dividend of ₹5 per equity share (face value ₹5) for FY ended March 31, 2026, subject to shareholder approval at the AGM. The filing provides detailed TDS rates and documentation requirements for resident and non-resident shareholders, with a deadline of September 11, 2026, for submitting documents to determine the applicable withholding tax rate. No financial performance data or period-over-period comparisons are included in this communication.
- · The final dividend of ₹5 per share was recommended by the Board on May 21, 2026, for FY ended March 31, 2026, and is subject to shareholder approval at the AGM.
- · No TDS is deducted for resident individual shareholders if total dividend during TY 2026-27 does not exceed ₹10,000.
- · Shareholders must submit required documents (PAN, declarations, tax residency certificates, etc.) by September 11, 2026, to enable the company to determine the appropriate TDS rate.
- · Non-resident shareholders without a PAN can now electronically file Form 41 to avail treaty benefits.
- · The company is not obligated to apply beneficial tax treaty rates at the time of withholding; application depends on completeness and satisfactory review of submitted documents.
- · TDS credit will be reflected in Form 168 on the income tax portal after dividend payment.
18-08-2026
Vinesh Shivji Dholu and four other acquirers have launched an open offer to acquire up to 33,82,231 equity shares (25.05% of expanded share capital) of Lippi Systems Limited at ₹56.84 per share, with the offer opening on July 20, 2026 and closing on July 31, 2026. The acquirers, who currently hold no shares, aim to gain control through a share purchase agreement and preferential warrants, targeting a post-offer shareholding of 99.63% under full acceptance. However, the actual acceptance was minimal (only 1,000 shares tendered), resulting in a post-offer holding of just 74.58% for the acquirers, while the public retains 25.05% of the expanded capital.
- · The offer was made under Regulation 3(1) and 4 of SEBI (SAST) Regulations.
- · The Detailed Public Statement was published on May 25, 2026 in Financial Express (English), Jansatta (Hindi), Navshakti (Marathi), and Financial Express (Regional).
- · The Letter of Offer was dated July 8, 2026.
- · The pre-offer advertisement cum corrigendum was published on July 17, 2026.
- · Payment of consideration was made on August 10, 2026.
- · Under the Share Purchase Agreement dated May 18, 2026, acquirers agreed to purchase 1,00,67,969 shares (74.57% of expanded capital) via preferential warrants.
- · Post-offer, the public shareholding reduced from 33,82,231 shares to 33,81,231 shares (due to reclassification of 49,800 shares from promoter to public).
- · The expanded share capital includes 70,00,000 existing shares and 65,00,000 shares underlying warrants.
18-08-2026
Kama Holdings Limited has informed BSE that it has provided a facility for shareholders to submit documents to apply for a lower rate of Tax Deducted at Source (TDS) on the interim dividend declared on August 14, 2026. Shareholders must submit the required details by August 21, 2026, to enable the company to determine and deduct appropriate TDS at the time of dividend payment.
- · The facility for lower TDS deduction is available for the interim dividend declared on August 14, 2026.
- · Shareholders must submit required documents by August 21, 2026.
- · Details and list of documents are available on the company's website at the provided link.
18-08-2026
Kesar Petroproducts Ltd's Board meeting on 14 August 2026 approved unaudited standalone financial results for the quarter ended 30 June 2026, recommended re-appointment of Mr. Ramjan Kadar Shaikh as Whole-time Director for a second term, and fixed 28 September 2026 as the date for the 36th Annual General Meeting via VC/OAVM. The filing also includes routine governance items such as appointment of scrutinizer, internal auditor, and book closure dates. No financial figures, period‑over‑period comparisons, or material business updates were disclosed in this market notice.
- · The Board approved the re‑appointment of Mr. Ramjan Kadar Shaikh as Whole‑time Director for a second term of 5 years, subject to shareholder approval at the AGM.
- · Mr. Ramjan Kadar Shaikh will retire by rotation and offer himself for re‑appointment as Director at the AGM.
- · 36th AGM scheduled for 28 September 2026 at 1:00 PM via VC/OAVM.
- · Book closure for AGM from 22 September 2026 to 28 September 2026 (both days inclusive).
- · E‑voting period: 25 September 2026 (9:00 AM) to 27 September 2026 (5:00 PM).
- · Scrutinizer's report and declaration of results on or before 30 September 2026.
- · M/s. ATJ & Co. LLP Jain appointed as Internal Auditor for FY 2026‑27.
18-08-2026
Autoline Industries Limited has informed the exchanges that Informatics Valuation and Rating Private Limited has reaffirmed its long-term rating at IVR BBB-/Stable and short-term rating at IVR A3 for total bank loan facilities of Rs. 243.00 Crore (enhanced from Rs. 150.50 Crore). The reaffirmation reflects the rating agency's assessment of the company's operational and financial performance for FY 2025-26 (Audited).
- · Long-term rating reaffirmed at IVR BBB- / Stable
- · Short-term rating reaffirmed at IVR A3
- · Rating action date: August 17, 2026
- · Filing date: August 18, 2026
18-08-2026
The Acquirers (Vinesh Shivji Dholu, Jagdish Shivji Dholu, Shivji Karamshi Dholu, Jagruti Vinesh Dholu, and Parul Jagdish Dholu) completed an Open Offer to acquire up to 33,82,231 equity shares (25.05% of expanded capital) of Lippi Systems Ltd. at ₹56.84 per share. However, actual public acceptance was minimal—only 1,000 shares were tendered and accepted—resulting in the Acquirers' post-offer shareholding reaching only 74.58% (versus a potential 99.63%). The offer was managed by Vivro Financial Services Private Limited and the consideration was paid on August 10, 2026.
- · The open offer opened on July 20, 2026 and closed on July 31, 2026.
- · Consideration was paid on August 10, 2026.
- · The Acquirers had zero shareholding before the agreements/public announcement.
- · Under the Share Purchase Agreement dated May 18, 2026, the Acquirers will acquire 1,00,67,969 shares (74.57% of expanded capital).
- · Post-offer, the Acquirers' combined shareholding is 1,00,68,969 shares (74.58%) versus a potential 1,34,50,200 shares (99.63%) if the offer had been fully subscribed.
- · The public shareholding post-offer remains at 33,81,231 shares (25.05%) because only 1,000 shares were accepted from the public.
- · The Sellers and other promoter group members holding 49,800 shares will be reclassified from 'promoter' to 'public' after the SPA consummation.
18-08-2026
JSW Dulux Limited (formerly Akzo Nobel India) reported Q1 FY27 revenue of ₹965 Cr, up 18.8% YoY on a like-to-like basis, driven by 25% volume growth. Decorative and industrial businesses both grew strongly, with industrial exceeding 25%. However, gross margin fell to 37.4% due to low inventory (60 days in decorative) and a reclassification of promotional spends, while EBITDA margin declined to 11.9% as the company reinvested in R&D and added ~160 people. PAT of ₹135.5 Cr included one-off items: ₹55.9 Cr dividend from ICI R&T and ₹21.5 Cr interest on an IT refund.
- · Company moved headquarters from Delhi to JSW Center in Mumbai during the quarter.
- · Decorative business inventory was only ~60 days vs industry 110-120 days, causing a gross margin hit.
- · Underlying gross margin (excluding crude impact and reclassification) estimated at 39.5%-40%.
- · EBITDA margin guidance for the year: 13%-15%.
- · Income tax refund of ₹108 Cr for AY 2013-14 received, including ₹21.5 Cr interest.
- · Company plans to increase active town presence from ~3,400 to 4,500 towns this year.
- · Focus on premium categories, adjacencies (Waterproofing), and undercoat products (primers).
18-08-2026
Stallion India Fluorochemicals Limited has informed the stock exchanges that the audio recording of its earnings conference call held on August 17, 2026, to discuss the unaudited financial results for the quarter ended June 30, 2026, is now available on the company's website. The filing is a procedural disclosure under SEBI regulations and does not contain any financial results or performance data.
- · Earnings conference call was held on August 17, 2026, at 4:00 PM IST.
- · Audio recording is available at https://stallionfluorochemicals.com/investors-information/earning-call/.
- · The call discussed unaudited financial results for the quarter ended June 30, 2026.
18-08-2026
Vadilal Industries Limited has fixed September 3, 2026 as the Record Date for determining shareholder eligibility for the final dividend for FY2025-26. The Register of Members and Share Transfer Books will remain closed from September 4 to September 10, 2026. No dividend amount is specified in the filing.
- · Record Date: Thursday, 03rd September, 2026
- · Book closure period: 04th September, 2026 to 10th September, 2026 (both days inclusive)
- · Dividend amount not disclosed in this filing
18-08-2026
18-08-2026
Pasupati Acrylon Limited has issued a reminder to its physical shareholders to furnish/update PAN, KYC, nomination, bank account details, and specimen signature, as mandated by SEBI Master Circular dated February 6, 2026. Shareholders who fail to comply will be ineligible to lodge grievances or avail service requests from the company's RTA. The company has provided the necessary forms (ISR-1, ISR-2, SH-13, ISR-3, SH-14) and contact details for the RTA, MCS Share Transfer Agent Limited.
- · Shareholders holding shares in physical mode who have not updated PAN and KYC details shall not be eligible to lodge grievance or avail any service request from the company’s RTA.
- · PAN must be linked with Aadhaar; otherwise, PAN will be deemed invalid and the folio will be treated as if no PAN has been furnished.
- · The reminder is sent pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- · Forms required: ISR-1 (PAN, KYC details), ISR-2 (signature confirmation by banker), SH-13 (nomination), ISR-3 (opt-out of nomination), SH-14 (cancellation/change in nomination).
- · RTA address: MCS Share Transfer Agent Limited, 179-180, 3rd Floor, DSIDC Shed, Okhla Industrial Area, Phase – 1, New Delhi – 110020.
18-08-2026
Kirloskar Industries Limited held its Annual General Meeting (AGM) on August 18, 2026, via video conferencing, where shareholders approved the adoption of audited financial statements for FY ended March 31, 2026, and declared a dividend of ₹13 per equity share (130%). The meeting also re-appointed directors Vinesh Kumar Jairath and Anil Alawani, and re-appointed M/s. Kirtane & Pandit LLP as statutory auditors for a second term until 2031. The meeting lasted from 11:30 AM to 12:39 PM IST.
- · The AGM was conducted via Video Conferencing/OAVM in compliance with MCA Circulars and SEBI regulations.
- · Mr. Anil Alawani was re-appointed as Non-Executive Director for a period of one year up to the 2027 AGM.
- · M/s. Kirtane & Pandit LLP were re-appointed as Statutory Auditors for a second term of five years, from the 32nd AGM to the 37th AGM (2031).
- · Voting results and the Scrutinizer's report will be submitted separately under Regulation 44.
18-08-2026
AUDROC Limited (formerly Alka India Ltd) has allotted 7,50,00,000 (Seven Crore Fifty Lakhs) Fully Convertible Equity Warrants at ₹4.00 per warrant (including ₹3.00 premium) to two non-promoter allottees on a preferential basis. The allotment is the fifth tranche under a special resolution passed in June 2026 and in-principle approval from BSE. The company received 25% of the consideration upfront, and there is no immediate change in paid-up share capital.
- · The warrants are convertible into equity shares of face value ₹1 each within a maximum of 18 months from allotment date.
- · The issue price includes a premium of ₹3.00 per warrant over the face value of ₹1.
- · The board meeting lasted 10 minutes (12:30 PM to 12:40 PM).
- · The company's name was changed from Alka India Limited to AUDROC Limited.
- · The post-issue shareholding percentages (18.16% each) are computed assuming full allotment of 20,00,00,000 warrants across all tranches, not just this fifth tranche.
18-08-2026
Birla Corporation Limited disclosed that ESG Risk Assessments & Insights Limited has voluntarily assigned an ESG score of 63 to the company based on publicly available information. The company clarified that it did not engage the rating agency for this assessment. The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015.
- · The ESG rating was received by the company on 17th August 2026 at 10:25 p.m. IST.
- · The company has not engaged ESG Risk Assessments & Insights Limited for the ESG rating; it was independently assigned based on publicly available information.
18-08-2026
The Reserve Bank of India conducted a 1-day Overnight Variable Rate Reverse Repo (VRRR) auction on August 18, 2026, with a notified amount of ₹75,000 crore. The auction received total offers of ₹36,595 crore, all of which were accepted at a cut-off rate of 5.24%, resulting in a weighted average rate of 5.24%. The partial acceptance percentage was not applicable as offers matched the accepted amount exactly.
- · The auction had a accepted-to-notified amount ratio of approximately 48.8% (₹36,595 crore accepted out of ₹75,000 crore notified).
- · The partial acceptance percentage of offers received at cut-off rate is marked 'N.A.' as all offers were accepted.
18-08-2026
Mukesh Sangla, a promoter of Signet Industries Limited, acquired 13,904 equity shares (0.05% of diluted capital) via open market purchase on August 17, 2026. This increased his total holding from 1,169,885 shares (3.97%) to 1,183,789 shares (4.02%). The acquisition is a routine insider disclosure under SEBI SAST regulations and does not represent a material change in control or strategy.
- · The acquisition was made from the open market on August 17, 2026.
- · No shares were encumbered (pledged) before or after the transaction.
- · The promoter's stake remains below the 5% threshold that would trigger additional disclosure requirements.
18-08-2026
Natural Capsules Limited has called an Extraordinary General Meeting (EGM) on September 9, 2026, to seek shareholder approval for two preferential allotments to promoter Mr. Sunil Laxminarayan Mundra. The proposals include issuing 1,25,000 equity shares at ₹160 each (aggregating ₹2,00,00,000) and up to 5,00,000 warrants convertible into equity shares at ₹160 each (aggregating ₹8,00,00,000). The EGM will be held via video conference, and the resolutions are classified as special business requiring special resolutions.
- · The EGM is scheduled for Wednesday, September 9, 2026, at 12:00 PM IST via video conference.
- · The relevant date for determining the minimum price for the preferential allotment is August 10, 2026.
- · Warrants have a tenure of 18 months from allotment; unexercised warrants will expire and the subscription amount will be forfeited.
- · Warrants carry no voting rights until converted into equity shares.
- · Equity shares and shares resulting from warrant conversion will rank pari passu with existing shares.
- · Allotment of equity shares must be completed within 15 days of passing the special resolution (or receipt of last regulatory approval).
18-08-2026
Citius TransNet Investment Trust announced that its Investment Manager representatives will participate in meetings with analysts and investors from August 19 to August 25, 2026. Discussions will be limited to publicly available information, and no unpublished price-sensitive information will be disclosed.
- · Meeting period: August 19, 2026 to August 25, 2026
- · Investment Manager: EAAA TransInfra Managers Limited
- · Trustee: Axis Trustee Services Limited
18-08-2026
ABATE AS INDUSTRIES LIMITED has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in compliance with SEBI regulations. The results were advertised in Trinity Mirror (English) and Makkal Kural (Tamil) newspapers on August 15, 2026. The filing is a routine disclosure of financial results and does not contain any specific financial figures or performance data.
- · The advertisement was published on August 15, 2026, in Trinity Mirror (English) and Makkal Kural (Tamil) newspapers.
- · The filing is made under Regulations 30, 33, and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- · The company's CIN is L65990TZ1991PLC029162 and its scrip code is 531658.
18-08-2026
The filing is a corporate governance update for Panafic Industrials Ltd, dated August 18, 2026. The document contains extensive garbled text, making it impossible to extract any specific financial figures, named entities, or material business developments. No actionable quantitative data or period-over-period comparisons can be derived from the filing.
18-08-2026
KK Shah Hospitals Limited held its 4th Annual General Meeting on August 18, 2026, where shareholders approved the adoption of annual accounts, the re-appointment of Ms. Milli Shah as a retiring director, and the approval of directors' remuneration exceeding the overall managerial remuneration limit. The meeting was conducted physically without e-voting, as the company is exempted under MCA rules for SME-listed entities. No financial results or performance metrics were disclosed in the filing.
- · The AGM was held at the registered office in Ratlam, Madhya Pradesh.
- · The meeting lasted from 11:00 AM to 11:30 AM.
- · The statutory auditors' report for the year ended March 31, 2026, contained no qualifications, observations, or comments.
- · The company is exempted from e-voting requirements under MCA notification dated March 19, 2015.
- · Voting was conducted via polling papers/ballot papers for members on record as of the cut-off date August 11, 2026.
- · Voting results will be announced within two working days after receipt of the Scrutinizer's report.
18-08-2026
InfoBeans Technologies Limited held its 16th Annual General Meeting on August 7, 2026, where all three resolutions were passed unanimously with over 99.99% approval. The meeting approved the audited financial statements for FY2025-26, re-appointed Mr. Avinash Sethi as a director retiring by rotation, and declared a final dividend of INR 0.50 per share plus a special dividend of INR 0.50 per share. No shareholder queries were raised, and the auditors' report contained no qualifications or adverse comments.
- · Meeting duration: 27 minutes (4:00 PM to 4:27 PM)
- · Remote e-voting period: August 3, 2026 (9:00 AM) to August 6, 2026 (5:00 PM IST)
- · Cut-off date for voting eligibility: July 31, 2026
- · No shareholder queries were raised during the meeting
- · Auditors' report had no qualifications, observations, or adverse comments
18-08-2026
Moongipa Capital Finance Ltd. has informed BSE that a Board meeting will be held on August 24, 2026, to consider the draft Board's Report, the re-appointment of a director retiring by rotation, the AGM schedule, appointment of a scrutinizer, closure of the register of members, and re-appointment of internal auditors. The filing is a routine procedural intimation with no financial results or material business developments disclosed.
- · Board meeting scheduled for August 24, 2026.
- · Agenda includes approval of draft Board's Report, re-appointment of Mr. Sanjay Jain (retiring by rotation), fixing AGM date, appointing scrutinizer, closure of Register of Members, and re-appointment of M/s R. Mahajan & Associates as internal auditors.
18-08-2026
Kusumgar Ltd reported a strong 102% YoY revenue growth to INR247.2 crore in Q1 FY27, driven by execution of ready parachute contracts. EBITDA margin expanded 900 bps YoY to 31%, and PAT surged to INR42.6 crore (17% margin) from INR6.6 crore (5% margin) a year ago. However, revenue declined 21% sequentially from INR312.8 crore in Q4 FY26, which management attributed to a pull-forward of export volumes due to US tariff resolution, and the company declined to provide forward guidance citing structural uncertainties in government tenders and product approvals.
- · Company listed on NSE and BSE on July 15, 2026.
- · Management declined to provide forward guidance due to structural uncertainties: 90% of business linked to long-standing product approvals, meaningful portion from government tenders, global footprint with tariff volatility.
- · Company operates as a single segment for reporting purposes; no segmental revenue breakup provided.
- · Revenue CAGR of ~35% and PAT CAGR of >70% from FY20 to FY26.
- · Company is one of only two global suppliers of zero-porosity parachute fabric and the only Indian manufacturer of Kevlar filament fabrics.
- · Exclusive partnerships with global leaders provide access to IP and know-how.
18-08-2026
Jaykay Enterprises Limited has informed the stock exchanges that its Rights Issue Committee will meet on August 20, 2026 to decide the Issue Price, Entitlement Ratio and other terms for the proposed Rights Issue of partly paid-up equity shares (face value Re.1 each). The trading window for dealing in the company's securities has been closed from August 18, 2026 until 48 hours after the committee meeting. No financial figures or prior-period comparisons are provided in this filing.
- · The Rights Issue Committee meeting is scheduled for August 20, 2026.
- · The trading window is closed from August 18, 2026 until 48 hours after the committee meeting.
- · The Rights Issue was approved by the Board on July 13, 2026, with prior committee meetings on July 14 and July 17, 2026.
18-08-2026
Blue Jet Healthcare released its Annual Report for FY 2025-26, reporting revenue of ₹9,473 million, EBITDA of ₹2,941 million (31% margin), and PAT of ₹2,478 million (26% margin). The company raised ₹8,000 million via QIP, acquired 102.48 acres in Andhra Pradesh for a new facility, and launched SAP S/4HANA under 'Project Leap'. However, the filing does not provide prior-period comparisons, so performance trends cannot be assessed.
- · Company assigned CARE A1+ Short-term and CARE A+ Long-term rating by Care Ratings Limited.
- · Backward integration project at Mahad facility (Unit III) is on track.
- · Secured leasehold premises for an additional R&D centre in Hyderabad focusing on GLP-1 intermediates, peptide chemistry, bio-catalysis.
- · AGM scheduled for September 21, 2026 at 11:00 AM IST via VC/OAVM.
- · Revenue mix: 89.94% exports, 10.06% domestic.
- · ~40% savings in energy cost from renewable sources.
- · 37.5% women members on Board of Directors.
18-08-2026
Transpek Industry Ltd. has submitted its Annual Report for FY2025-26 and convened its 60th Annual General Meeting on September 15, 2026 via video conferencing. The report highlights a 83.10% revenue share from international markets, an EcoVadis Gold Medal (top 5% in the chemical sector), and a new 48-month AI roadmap. However, the filing does not disclose specific financial performance figures for the current year, making it impossible to assess revenue or profit growth, and the company's market capitalisation stood at ₹793.71 Crore as of December 31, 2025.
- · The company introduced three non-acid chloride products during FY2025-26 and has additional non-acid chloride products in advanced development stages expected to commercialise in FY2026-27.
- · A 10-year exclusive supply agreement with a global chemical major commenced on 1st January 2018 and continues to be EPS-accretive.
- · New customers were added in Eurasia and South America during the year.
- · The company reported zero environmental violation complaints and achieved its Scope 1, Scope 2 and Scope 3 emissions reduction targets for FY2025-26.
- · The AGM will be held without physical presence of shareholders at a common venue, in line with MCA and SEBI circulars.
18-08-2026
Blue Jet Healthcare Limited has issued the notice for its 58th Annual General Meeting (AGM) to be held on September 21, 2026 via video conferencing. The agenda includes adoption of audited financial statements for FY ended March 31, 2026, declaration of a final dividend of ₹1.20 per equity share, re-appointment of directors and statutory auditors, and special resolutions for the re-appointment of Mr. Akshay Bansarilal Arora as Whole-Time Director & Executive Chairman and Mr. Shiven Akshay Arora as Managing Director, both for five-year terms starting April 13, 2027. The filing is a routine procedural disclosure with no financial performance data or period-over-period comparisons provided.
- · The 58th AGM will be held on Monday, September 21, 2026 at 11:00 AM IST through Video Conferencing / Other Audio Visual Means.
- · The record date for the final dividend is Monday, September 14, 2026.
- · The e-voting period commences on Friday, September 18, 2026 (9:00 AM IST) and ends on Sunday, September 20, 2026 (5:00 PM IST).
- · Mr. Akshay Bansarilal Arora is proposed to be re-appointed as Whole-Time Director and Executive Chairman for a period of five years from April 13, 2027 to April 12, 2032.
- · Mr. Shiven Akshay Arora is proposed to be re-appointed as Managing Director for a period of five years from April 13, 2027 to April 12, 2032.
- · M/s. KKC & Associates LLP, Chartered Accountants, are proposed to be re-appointed as Statutory Auditors for a second term of five consecutive years from the conclusion of the 58th AGM until the conclusion of the 63rd AGM.
18-08-2026
Hexagon Nutrition Ltd reported strong Q1 FY27 results with consolidated revenue from operations of INR104.3 crore, up 43.2% YoY from INR72.9 crore. EBITDA grew 17.3% to INR11.8 crore and PAT rose 25.1% to INR8.1 crore. However, EBITDA margin contracted to 11.3% from 13.8% in Q1 FY26, reflecting product mix changes and growth investments.
- · First quarterly results announcement after listing on BSE and NSE in June 2026.
- · Export concentration: top 5 countries account for 25%-40% of export revenue.
- · West Asia contributes less than 20% of total exports; geopolitical situation there has not materially impacted business.
- · Capacity utilization is around 30% overall, with premix segment contributing over 50% of revenue.
- · Company serves customers across more than 70 countries.
- · Tender-based therapeutic nutrition business can cause quarterly order flow variability.
18-08-2026
Advait Energy Transitions Limited announced that its material subsidiary, Advait Greenergy Private Limited, has received a turnkey EPC contract from KPI Green Energy Limited for a 200 MW solar project in Bikaner, Rajasthan. The order is valued at ₹1,16,00,00,000 (₹116 Crore) excluding taxes and is to be executed within 12 months. The contract is in the normal course of business and is not a related-party transaction.
- · The order was received on August 17, 2026.
- · The contract is awarded by a domestic entity (KPI Green Energy Limited).
- · No promoter/promoter group/group companies interest in the awarding entity.
- · The contract is not a related-party transaction.
18-08-2026
Radaan Mediaworks India Limited announced the resignation of two directors effective August 18, 2026: Mr. Krishnachandar (Independent Director) and Ms. Radikaa Rayane (Non-Executive Director), both citing personal commitments. The resignations were disclosed under Regulation 30 of SEBI LODR, with no other material reasons provided. This reduces board independence and non-executive representation, but no immediate financial impact is disclosed.
- · Resignation effective from closing business hours on 18th August, 2026.
- · Resignation letters dated 17th August, 2026.
- · Mr. Krishnachandar holds DIN:10763027; Ms. Radikaa Rayane holds DIN:08350418.
- · Both directors confirmed no other material reasons for resignation.
- · No directorships or board committee memberships in other listed entities for Mr. Krishnachandar.
- · Disclosures made under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
18-08-2026
The Board of JMJ Fintech Limited approved a preferential issue of 7,90,000 equity shares at ₹20 each (₹10 face value + ₹10 premium), aggregating ₹158 Lakh (₹1,58,00,000), subject to shareholder and regulatory approvals. A final dividend of ₹0.15 per share for FY 2025-26 was recommended, and CA Methil Rajalakshmy was appointed as an Additional Independent Director for a one-year term. The 43rd AGM is scheduled for September 17, 2026 via video conferencing. The filing contains no financial results; therefore, no period-over-period comparisons are available.
- · Record date for dividend and e-voting is September 10, 2026; book closure from September 11 to 17, 2026.
- · Post-preferential allotment, promoter holding will decrease to 23.25% from 23.74%, while public holding will rise to 76.75% from 76.26%.
- · The issue price of ₹20 is approximately 101% above the floor price of ₹9.95 per share.
- · Committees reconstituted: Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, each including the new Independent Director.
- · CA Methil Rajalakshmy holds a DIN of 02718979 and is not related to any existing director.
18-08-2026
JMJ Fintech Limited's Board approved a final dividend of ₹0.15 per share for FY2025-26, a preferential issue of 7,90,000 equity shares at ₹20 each (aggregating ₹1,58,00,000), and the appointment of CA Methil Rajalakshmy as an Additional Independent Director. The 43rd AGM is scheduled for September 17, 2026 via video conferencing. While the dividend and capital raise signal confidence, the preferential issue will dilute promoter holding from 23.74% to 23.25%.
- · Record date for dividend and e-voting eligibility: September 10, 2026.
- · Book closure period: September 11 to September 17, 2026.
- · The preferential issue price of ₹20 per share is at a 101% premium to the floor price of ₹9.95.
- · Post-preferential allotment, public shareholding will increase from 76.26% to 76.75%.
- · The appointed scrutinizer for e-voting is M/s. Lakshmmi Subramanian & Associates, Practicing Company Secretaries.
- · CA Methil Rajalakshmy holds 27+ years of professional experience and is a Fellow Member of ICAI.
18-08-2026
Paul Merchants Ltd. has scheduled its 42nd Annual General Meeting (AGM) for September 18, 2026, to be held via video conferencing, with the annual report and notice to be sent electronically. The book closure period is set from September 4 to September 10, 2026, and remote e-voting will be open from September 15 to September 17, 2026. This filing is a procedural disclosure with no financial results or performance data.
- · AGM date: September 18, 2026 at 12:00 noon IST via VC/OAVM.
- · Book closure: September 4 to September 10, 2026 (both days inclusive).
- · Remote e-voting period: September 15, 2026 (9:00 AM IST) to September 17, 2026 (5:00 PM IST).
- · Cut-off date for e-voting eligibility: September 11, 2026.
- · Annual report will be available on company website (www.paulmerchants.net), BSE website, and CDSL e-voting portal.
- · Physical copies of annual report will be sent only to shareholders who request via email.
18-08-2026
Flair Writing Industries reported Q1 FY27 revenue of ₹319.2 Cr (+10.6% YoY) and EBITDA of ₹53.3 Cr (+7.7% YoY), with EBITDA margin at 16.7% (down 46 bps YoY). The Pen segment grew 9% YoY to ₹220 Cr, Creative Products grew 23% YoY to ₹80 Cr, and Steel Bottles & Houseware surged 54.3% YoY to ₹19 Cr. However, PAT grew only 0.5% YoY to ₹29.1 Cr due to lower other income and elevated raw material costs from geopolitical tensions, and exports remained flat YoY at ₹43 Cr. The company reiterated its FY27 revenue growth guidance of 15% and expects EBITDA margins to improve to 17-18% as cost pressures ease.
- · Gross margin stood at 49.7% in Q1 FY27 vs 50% in Q1 FY26 and 51.2% in Q4 FY26.
- · EBITDA margin target for FY27 is 17.5% to 18%.
- · Creative Products and Steel Bottles & Houseware together contributed ~31% of total revenue in FY26; expected to reach 35-38% in FY27.
- · Flair Cyrosil placed order for fourth manufacturing line; commissioning expected by Q4 FY27, increasing capacity by ~35%.
- · Company is zero debt; all internal accruals for future expansion.
- · Q1 FY27 capex of ₹43.42 Cr, including ₹33.25 Cr for Valsad factory building and ₹38.7 L for Surat molds.
- · Export growth was flat YoY due to West Asia disruptions; company focusing on other geographies.
- · Management expects cost pressures to ease over next three quarters as pricing interventions flow through.
18-08-2026
Rail Vikas Nigam Limited (RVNL) reported a steady Q1 FY2026-27 with standalone revenue of INR 4,300 crore (+9.62% YoY) and PAT of INR 155 crore (+21.72% YoY). The order book stood at INR 93,492 crore, diversified across railways, S&P, ports, roads, metros, power, and hydro. However, while EBITDA margins improved to 3.99% from 2.08% YoY, they remain low and are a key focus area. The company targets INR 20,000-25,000 crore in new orders for the year, with INR 5,500 crore already secured in Q1.
- · 42% of order book is on management fee basis (fixed margin), providing inflation protection.
- · BharatNet project (INR 13,000 Cr) faced initial execution challenges but is now progressing in UP West and UP East; payment issues with BSNL are being resolved.
- · Vande Bharat sleeper train project (INR 14,400 Cr) first prototype targeted for December 2026; SPV won Bronze A' Design Award 2026 in Italy.
- · Rishikesh-Karnaprayag rail project (INR 37,000 Cr) is 78% complete with 97% tunnel excavation; targeted completion by December 2029.
- · Subsidiaries contributed INR 126 Cr to consolidated revenue and INR 12.70 Cr to PAT in Q1.
- · Dividend income from JVs and subsidiaries stood at INR 12.07 Cr in Q1.
- · Revenue per employee improved to INR 4.97 Cr from INR 4.29 Cr QoQ.
- · Company is focusing on port, hydro, highway, and green energy sectors for new orders.
18-08-2026
JMJ Fintech Limited's Board approved a final dividend of ₹0.15 per share for FY2025-26, a preferential issue of 7,90,000 equity shares at ₹20 each (aggregating ₹1,58,00,000), and the appointment of CA Methil Rajalakshmy as an Additional Independent Director. The 43rd AGM is scheduled for September 17, 2026 via video conferencing. The preferential issue will dilute promoter holding from 23.74% to 23.25%, while public shareholding increases from 76.26% to 76.75%.
- · Record date for dividend and e-voting eligibility is September 10, 2026.
- · Book closure period: September 11, 2026 to September 17, 2026.
- · The preferential issue price of ₹20 per share is at a 101% premium to the floor price of ₹9.95 per share.
- · CA Methil Rajalakshmy holds DIN 02718979 and is appointed for a 1-year term subject to shareholder approval.
- · The company is a BSE Listed Non-Banking Financial Company (NBFC).
- · M/s. Lakshmmi Subramanian & Associates appointed as Scrutinizer for e-voting.
18-08-2026
Maxgrow India Ltd has published its unaudited financial results for the quarter ended June 30, 2026, and submitted newspaper publication copies to BSE Limited. The filing is a routine regulatory disclosure, but the actual financial figures in the attached newspaper clippings are illegible due to poor OCR quality, preventing any quantitative analysis.
- · The results were published in 'Financial Express' (English) and 'Mumbai Lakshadeep' (Marathi) newspapers on August 18, 2026.
- · The company's BSE Scrip Code is 521167.
- · The filing was signed by Director Shivkumar Ramsagar Pasi (DIN: 10869886).
18-08-2026
Samvardhana Motherson International Limited (MOTHERSON) informed exchanges that the National Company Law Tribunal (NCLT), Mumbai Bench-III, has approved the reduction of share capital of its subsidiary, Motherson Technology Services Limited (MTSL), by 7.04%. The reduction involves cancelling 78,58,602 equity shares held by minority shareholders at ₹42.66 per share (₹10 face value + ₹32.66 premium), totaling ₹33,52,47,961.32, making MTSL a wholly owned subsidiary of its parent entity. The order was received on August 17, 2026, and the reduction is aimed at streamlining the group structure and providing an exit to minority shareholders whose shares became illiquid after MTSL's voluntary delisting in FY2008-09.
- · The NCLT order was pronounced on August 13, 2026, and received by the company on August 17, 2026.
- · The reduction was approved by MTSL's Board on August 28, 2025, and by shareholders via a Special Resolution on September 29, 2025.
- · The fair value per share for the reduction was determined by an IBBI-registered valuer at ₹42.66 as on June 30, 2025.
- · MTSL's equity shares were voluntarily delisted from the Delhi Stock Exchange in FY2008-09, leaving minority shareholders with illiquid holdings.
- · MTSL's total equity as on March 31, 2025 was ₹2,281.5 million, with total assets of ₹6,342.8 million.
- · The reduction is being carried out under Section 66 and Section 52 of the Companies Act, 2013.
Get daily alerts with 10 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Stock Market Daily Regulatory Digest
August 16, 2026
India Stock Market Daily Regulatory Digest — August 16, 2026
August 15, 2026
India Stock Market Daily Regulatory Digest — August 15, 2026
August 14, 2026
India Stock Market Daily Regulatory Digest — August 14, 2026
August 13, 2026
India Stock Market Daily Regulatory Digest — August 13, 2026
🇮🇳 More from India
View all →August 19, 2026
India Upcoming Corporate Actions BSE NSE — August 19, 2026
India Upcoming Corporate Actions BSE NSE
August 19, 2026
India Pre-Market Regulatory Roundup — August 19, 2026
India Pre-Market Regulatory Roundup
August 19, 2026
India Quarterly Results BSE NSE Announcements — August 19, 2026
India Quarterly Results BSE NSE Announcements
August 19, 2026
India AGM EGM Shareholder Meeting Schedule — August 19, 2026
India AGM EGM Shareholder Meeting Schedule